Skip to main content

Military Health System

Pandemic Spotlights the Vital Role of Military Lab Workers

Image of U.S. Air Force Staff Sgt. Ashley Solomon, 18th Medical Support Squadron NCO in charge of microbiology, unloads blood samples from a centrifuge at Kadena Air Base, Japan, Jan. 31, 2019. (Photo: Tech. Sgt. Matthew B. Fredericks, U.S. Air Force). U.S. Air Force Staff Sgt. Ashley Solomon, 18th Medical Support Squadron NCO in charge of microbiology, unloads blood samples from a centrifuge at Kadena Air Base, Japan, Jan. 31, 2019. (Photo: Tech. Sgt. Matthew B. Fredericks, U.S. Air Force)

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response

Clinical labs across the Military Health System – and the staff who operate them – play a vital role in early detection of illnesses, diagnosis and treatment of diseases like cancer, diabetes or heart disease. 

In fact, studies show about 70% of current medical decisions depend on test results. 

The demands placed on MHS lab workers intensified during the past two years and the COVID-19 pandemic. 

“At the peak of the pandemic, most laboratories saw their workload double in some areas,” said Navy Hospital Corpsman 1st Class Aramatou Toure, assistant manager for the Defense Health Agency’s clinical laboratory improvement program. 

“Most laboratories had to re-evaluate their daily operation to address the staff shortage,” she recalled. 

Despite the challenges, lab staffs worked hard to keep pace with the demand and to deliver quality results to support clinicians. 

“The pandemic helped shine the light on the important role and work the laboratory does,” Toure said. “Most people were not aware of the background work performed by the laboratories in the process of patient diagnosis.”  

Moreover, the pandemic made it clear to many people that without the laboratories, clinicians cannot effectively perform their job.  

“The outside world, and other medical professionals were able to appreciate the work laboratories do, and I know that means a lot to the laboratory community,” Toure said. 

Air Force Lt. Col. Marybeth Luna, the director for the Department of Defense Center for Laboratory Medicine Services, already has plans to prepare for the next pandemic. 

“We encourage labs to utilize instrumentation that can analyze COVID, respiratory pathogens and other routine microbiological agents,” she said. 

“It’s very important to have analyzers that can convert from ‘peacetime’ uses as well as public health emergency responses. This ensures that labs always have on-site, emergency response capabilities as well as routine lab support,” Luna said. 

Every year, the last full week of April is observed as Medical Laboratory Professionals Week. Known as Lab Week, it began in 1975, and creates an opportunity to increase public awareness and appreciation for laboratory professionals. It is sponsored by the American Society for Clinical Laboratory Science and coordinated by 17 national clinical laboratory organizations. 

Within military medicine, the laboratory community consists of officers, who serve as lab managers, and enlisted service members, who do the actual testing and lab work. The civilians also do everything from sample collection to management. 

The lab techs “perform a wide variety of laboratory functions in order to provide data required to diagnose, treat, and monitor patient health,” explained Army Master Sgt. Roberto Laanan, the program manager for the Army Clinical Laboratory Improvement Program. 

Military clinical lab technicians and managers keep up with the latest technology via education and instruction. 

“The way we achieve accuracy is through training,” said Air Force Major Tatanya Cooper, deputy chief for the Laboratory Medicine Services. 

“Our military trained laboratorians received a minimum of one year of didactic and hands-on training, two to three years of thorough ‘upgrade’ training, as well as an annual competency training,” Cooper said.

You also may be interested in...

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

Establishes the DHA's procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits for enduring COVID-19 support.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

Supplemental Guidance for Providing DOD Coronavirus Disease 2019 Vaccines to DOD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

Showing results 1 - 12 Page 1 of 1
Refine your search
Last Updated: May 02, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery